A company from Tübingen, which is researching a vaccine against SARS CoV 2, arouses desires in the Trump administration. The federal government is trying to prevent the United States from securing exclusive rights to the drug.
There are allegedly conflicts between Germany and the United States over a Tübingen company that is working on a vaccine against the coronavirus. That reports the “Welt am Sonntag”. US President Donald Trump is trying to lure German scientists to America with high financial donations or to secure the drug exclusively for his country, the newspaper writes, citing government circles in Berlin.
The US President allegedly offers the company a large amount to secure its work exclusively. Trump is doing everything possible to get a vaccine for the United States. “But only for the United States,” according to the newspaper, according to the federal government.
On request, the Federal Ministry of Health referred to statements that a ministry spokesman had already made to “Welt am Sonntag”. “The Federal Government is very interested in the fact that vaccines and active substances against the novel corona virus are also being developed in Germany and Europe,” it says. “In this regard, the government is in intensive exchange with the company CureVac.”
Germany, according to the newspaper, tries to keep the company with financial offers. CureVac is working with the Paul Ehrlich Institute for Vaccines and Biomedical Medicines to produce a vaccine against the virus. The company did not want to comment on the events.
– .
